The use of dextromethorphan (DXM) in medicine has been around for decades. It is a common ingredient in many over-the-counter (OTC) cough medicines, and is also used to treat certain types of pain. Recently, however, there has been a rise in the use of high-dose DXM for recreational purposes. This has led to an increase in potential health risks, particularly among adolescents and young adults. In this article, we will explore the effects of high-dose DXM and discuss why it is important for doctors to be aware of the potential risks associated with its use.
Dextromethorphan (DXM) is an opioid derivative that is commonly found in OTC cough and cold medicines. It works by blocking the cough reflex, which helps to suppress coughing. DXM is also used to treat certain types of pain, such as neuropathic pain. It is available in both tablet and liquid forms, and is typically taken in doses of 10-30 milligrams (mg) per day.
High-dose DXM is defined as taking more than 30 mg of DXM in a single dose, or taking multiple doses of DXM throughout the day. This type of DXM use is also known as “stacking”, and it is becoming increasingly popular among adolescents and young adults. High-dose DXM is often taken to achieve a “high”, or to experience a sense of euphoria.
There are a number of potential health risks associated with high-dose DXM use. These include an increased risk of liver damage, increased heart rate and blood pressure, and increased risk of seizures. Additionally, high-dose DXM can lead to an increased risk of addiction and dependence.
High-dose DXM use has also been associated with a number of neuropsychiatric effects, such as confusion, disorientation, and hallucinations. These effects can be particularly dangerous, as they can lead to impaired decision-making and an increased risk of self-harm or injury.
High-dose DXM use can also lead to long-term effects, such as memory loss, cognitive impairment, and depression. Additionally, it has been linked to an increased risk of developing certain types of cancers, such as liver and kidney cancer.
Given the potential health risks associated with high-dose DXM use, it is important for doctors to be aware of the dangers associated with this type of drug use. Doctors should be aware of the signs and symptoms of DXM use, and should be prepared to provide appropriate treatment and support to those who are struggling with addiction. Additionally, doctors should be aware of the potential long-term effects of high-dose DXM use, and should be prepared to provide appropriate follow-up care and monitoring.
High-dose DXM use is becoming increasingly popular among adolescents and young adults, and it is associated with a number of potential health risks. It is important for doctors to be aware of the potential dangers associated with this type of drug use, and to be prepared to provide appropriate treatment and support to those who are struggling with addiction. By understanding the effects of high-dose DXM, doctors can help to ensure that their patients are safe and healthy.
1.
Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.
2.
New policy review highlights the importance of health-related quality of life in advanced cancer
3.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
4.
Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities
5.
More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.
1.
The Benefits of Understanding Haptoglobin High: What You Need to Know
2.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
3.
Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment
4.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
5.
Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
5.
Blood Clotting Disorders Explained
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation